{
  "docId": "019de516-de84-709f-9864-0c2e708269aa",
  "docSlug": "d2a0e3b4a50bc196c7afb3f2c93e5906",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 38 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 38,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "kpi_overview",
  "function": "frame_situation",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-de84-709f-9864-0c2e708269aa/15",
  "deckHref": "/decks/019de516-de84-709f-9864-0c2e708269aa",
  "deckJsonHref": "/decks/019de516-de84-709f-9864-0c2e708269aa.json",
  "deckAnchorHref": "/decks/019de516-de84-709f-9864-0c2e708269aa#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.34,
        "w": 0.537,
        "x": 0.42,
        "y": 0.38
      },
      "kind": "chart",
      "text": "Miebo Weekly TRx¹ ~13,600 Total TRx in Five Weeks Post Launch 531 1,946 3,222 3,926 3,976² 9/15 9/22 9/29 10/6 10/13 Week Ending",
      "attrs": {
        "chart_type": "line"
      },
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f16d143-8b03-4bfa-a8c3-f61d663035cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.159,
        "w": 0.249,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "image",
      "text": "Miebo (perfluorohexyloctane ophthalmic solution)",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4e78a25-b537-4c71-b55d-2b1ad10308a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.34,
        "w": 0.36,
        "x": 0.048,
        "y": 0.38
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "809827fe-84fd-4475-8e3e-b848962d2825",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.259,
        "x": 0.326,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "First-in-class prescription eye drop approved for dry eye disease (DED) that directly targets tear evaporation",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d0ef35a-e48a-495e-80e6-fda687e7b04d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.281,
        "x": 0.64,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "DED affects more than 38 million Americans, with ~90% experiencing evaporative dry eye³",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b63354bd-daff-4fe5-b1ef-2fe743bf08d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.29,
        "x": 0.65,
        "y": 0.789
      },
      "kind": "quote",
      "text": "\"With Miebo, ECPs can take a new approach to DED with a first-in-class option.\" Paul Karpecki, OD",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f4fca5a-a89d-4873-945b-5db1c4c9c941",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.29,
        "x": 0.048,
        "y": 0.789
      },
      "kind": "quote",
      "text": "\"Miebo is potentially a transformative medication, a revolution in the dry eye space.” Darrell White, MD",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e12c10db-772a-4f58-8a53-69d1ab9cef72",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.29,
        "x": 0.35,
        "y": 0.789
      },
      "kind": "quote",
      "text": "\"This launch will be a game changer because Miebo works, pure and simple.\" John Sheppard, MD",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6fbce51-4897-461c-aca3-499a004e20cf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.84,
        "x": 0.048,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. Data source: IQVIA XPO and BlinkRx. 2. TRx for week ending 10/13 reflects shortened week due to holiday. 3. Downs P. 2020 Dry Eye Products Market Report: A Global Analysis for 2019 to 2025. Market Scope; 2020. | Lemp, MA, Crews, LA, Bron AJ. (2012). Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Clinic-Based Cohort: a retrospective study. Cornea, 31(5), 472-478. 2012;31(5):472-478. doi:10.109/ICO.0b013e318225415a.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e15c503-73be-4043-9cdc-2586341c194b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.669,
        "x": 0.048,
        "y": 0.09
      },
      "kind": "title",
      "text": "Launched Miebo in Q3, Strong Early Performance",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57690629-78fa-4e53-85fb-253df7c2e867",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 13,
      "beatId": "d76085c2-7614-4652-81f9-fe73baff9b13",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The deck outlines strategic initiatives to drive growth momentum.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 17,
      "from": 14,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "6190ac6f-cdb0-4539-ab6e-48d558874b1d",
      "evidence": "The deck highlights the importance of taking action to strengthen supply chain.",
      "position": 1,
      "objective": "What are the consequences of not taking action to strengthen supply chain?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}